A Safety and Efficacy Study of Tralokinumab in Adults with Asthma

Study identifier:CD-RI-CAT-354-1049

ClinicalTrials.gov identifier:NCT01402986

EudraCT identifier:2011-001360-21

CTIS identifier:N/A

Study Complete

Official Title

A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults with Uncontrolled, Severe Asthma

Medical condition

asthma

Phase

Phase 2

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

689

Study type

Interventional

Age

18 Years - 75 Years

Date

Study Start Date: 01 Aug 2011
Primary Completion Date: 01 Jun 2013
Study Completion Date: 01 Feb 2014

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Mar 2017 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria